Roest, S., Kaffka Genaamd Dengler, S. E., van Suylen, V., van der Kaaij, N. P., Damman, K., van Laake, L. W., Bekkers, J. A., Dalinghaus, M., Erasmus, M. E., & Manintveld, O. C. (2020). Waiting list mortality and the potential of donation after circulatory death heart transplantations in the Netherlands. Netherlands Heart Hournal. https://doi.org/10.1007/s12471-020-01505-y

Bouma, B. J., Sieswerda, G. T., Post, M. C., Ebels, T., van Kimmenade, R., de Winter, R. J., & Mulder, B. J. (2020). New developments in adult congenital heart disease. Netherlands Heart Journal, 28(SUPPL 1), S44-49. https://doi.org/10.1007/s12471-020-01455-5

Crijns, H. J. G. M., & Van Gelder, I. C. (2020). Paradigm shifts in pathophysiology and management of atrial fibrillation-a tale of the RACE trials in the Netherlands. Netherlands Heart Journal, 28(SUPPL 1), S3-S12. https://doi.org/10.1007/s12471-020-01476-0

Meems, L. M. G., van Veldhuisen, D. J., & de Boer, R. A. (2020). Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care. Netherlands Heart Journal, 28(SUPPL 1), 31-38. https://doi.org/10.1007/s12471-020-01453-7

Boersma, L., Rienstra, M., & de Groot, J. R. (2020). Therapeutic options for patients with advanced atrial fibrillation: from lifestyle and medication to catheter and surgical ablation. Netherlands Heart Journal, 28(SUPPL 1), 13-18. https://doi.org/10.1007/s12471-020-01447-5

Hoes, M. F., te Riele, A. S. J. M., Gladka, M. M., Westenbrink, B. D., van Hout, G. P. J., van den Hoogenhof, M. M. G., Ghigo, A., Bollini, S., Purcell, N. H., Sohaib, S. M. A., Kardys, I., & Kuster, D. W. D. (2020). Young@Heart: empowering the next generation of cardiovascular researchers. Netherlands Heart Journal, 28(SUPPL 1), S25-30. https://doi.org/10.1007/s12471-020-01454-6

DOSIS consortium (2020). Strength of patient cohorts and biobanks for cardiomyopathy research. Netherlands Heart Journal, 28(Suppl 1), S50-S56. https://doi.org/10.1007/s12471-020-01456-4

Felix, S. E. A., de Jonge, N., Caliskan, K., Birim, O., Damman, K., Kuijpers, M., Tops, L. F., Palmen, M., & Ramjankhan, F. Z. (2020). The role of long-term mechanical circulatory support in patients with advanced heart failure. Netherlands Heart Journal, 28(SUPPL 1), 115-121. https://doi.org/10.1007/s12471-020-01449-3

Panman, S. C. M. D., ter Maaten, J. M., & Blaauw, Y. (2020). A young man with out-of-hospital cardiac arrest: it goes round and round. Netherlands Heart Journal. https://doi.org/10.1007/s12471-020-01481-3

EURO ENDO Investigators Grp, El Kadi, S., van den Buijs, D. M. F., Meijers, T., Gilbers, M. D., Bekkers, S. C. A. M., van Melle, J. P., Riezebos, R. K., Blok, W. L., Tanis, W., Wahadat, A. R., Roos-Hesselink, J. W., van der Spoel, T. I. G., Chamuleau, S. A. J., & Kamp, O. (2020). Infective endocarditis in the Netherlands: current epidemiological profile and mortality An analysis based on partial ESC EORP collected data. Netherlands Heart Hournal, 28(10), 526-536. https://doi.org/10.1007/s12471-020-01431-z

Mulder, B. A., Ten Berg, J., Ten Cate, H., van Es, N., Hemels, M. E. W., Kappelle, L. J., Bearda Bakker, H. B., de Borst, G. J., Drenth, D. J., Geersing, G. J., & Rienstra, M. (2020). Complex clinical scenarios with the use of direct oral anticoagulants in patients with atrial fibrillation: a multidisciplinary expert advisory board. Netherlands Heart Hournal, 28(10), 504-513. https://doi.org/10.1007/s12471-020-01424-y

Bergstra, A., Simsek, C., & van den Heuvel, A. F. M. (2020). Mitral regurgitation: when to intervene? A historical perspective. Netherlands Heart Hournal, 28(5), 266-271. https://doi.org/10.1007/s12471-020-01417-x

Brugts, J. J., Veenis, J. F., Radhoe, S. P., Linssen, G. C. M., van Gent, M., Borleffs, C. J. W., van Ramshorst, J., van Pol, P., Tukkie, R., Spee, R. F., Emans, M. E., Kok, W., van Halm, J. A., Handoko, L., Beeres, S. L. M. A., Post, M. C., Boersma, E., Lenzen, M. J., Manintveld, C., ... de Boer, R. A. (2020). A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure Design and rationale of the MONITOR HF multicentre randomised clinical trial. Netherlands Heart Journal, 28(1), 16-26. https://doi.org/10.1007/s12471-019-01341-9

van der Werf, H. W., Vlaar, P. J., van der Harst, P., & Lipsic, E. (2019). Development and first results of a dedicated chronic total occlusion programme. Netherlands Heart Hournal. https://doi.org/10.1007/s12471-019-01348-2

Dutch Maternal Mortality Morbidity, Lameijer, H., Schutte, J. M., Schuitemaker, N. W. E., van Roosmalen, J. J. M., & Pieper, P. G. (2019). Maternal mortality due to cardiovascular disease in the Netherlands: a 21-year experience. Netherlands Heart Hournal, 28, 27-36. https://doi.org/10.1007/s12471-019-01340-w

Vehmeijer, J. T., Koyak, Z., Zwinderman, A. H., Harris, L., Peinado, R., Oechslin, E. N., Silversides, C. K., Bouma, B. J., Budts, W., van Gelder, I. C., Oliver, J. M., Mulder, B. J. M., & de Groot, J. R. (2019). PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design. Netherlands Heart Hournal, 27(10), 474-479.

Bosman, L. P., Verstraelen, T. E., van Lint, F. H. M., Cox, M. G. P. J., Groeneweg, J. A., Mast, T. P., van der Zwaag, P., Volders, P. G. A., Evertz, R., Wong, L., de Groot, N. M. S., Zeppenfeld, K., van der Heijden, J. F., van den Berg, M. P., Wilde, A. A. M., Asselbergs, F. W., Hauer, R. N. W., Riele, A. S. J. M. T., Peter Van Tintelen, J., & Netherlands ACM Registry (2019). The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update. Netherlands Heart Hournal, 27(10), 480-486. https://doi.org/10.1007/s12471-019-1270-1

Benjamins, J. W., Hendriks, T., Knuuti, J., Juarez-Orozco, L. E., & van der Harst, P. (2019). A primer in artificial intelligence in cardiovascular medicine. Netherlands Heart Hournal, 27(9), 392-402. https://doi.org/10.1007/s12471-019-1286-6

Benjamins, J. W., van Leeuwen, K., Hofstra, L., Rienstra, M., Appelman, Y., Nijhof, W., Verlaat, B., Everts, I., den Ruijter, H. M., Isgum, I., Leiner, T., Vliegenthart, R., Asselbergs, F. W., Juarez-Orozco, L. E., & van der Harst, P. (2019). Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands: CVON-AI consortium. Netherlands Heart Hournal, 27(9), 414-425. https://doi.org/10.1007/s12471-019-1281-y

Jacobs, M. S., van Hulst, M., Campmans, Z., & Tieleman, R. G. (2019). Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions. Netherlands Heart Hournal, 27(7-8), 371-377. https://doi.org/10.1007/s12471-019-1267-9

ter Avest, E., & Lameijer, H. (2019). 'PARAMEDIC-2: Big study, small result'. Netherlands Heart Hournal, 27(7-8), 341-342. https://doi.org/10.1007/s12471-019-1302-x

van Lint, F. H. M., Mook, O. R. F., Alders, M., Bikker, H., Deprez, R. H. L. D., & Christiaans, I. (2019). Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance. Netherlands Heart Hournal, 27(6), 304-309. https://doi.org/10.1007/s12471-019-1250-5

Al-Jazairi, M. I. H., Rienstra, M., Klinkenberg, T. J., Mariani, M. A., van Gelder, I. C., & Blaauw, Y. (2019). Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation. Netherlands Heart Hournal, 27(3), 142-151. https://doi.org/10.1007/s12471-019-1228-3

Hof, I. E., van der Heijden, J. F., Kranias, E. G., Sanoudou, D., de Boer, R. A., van Tintelen, J. P., van der Zwaag, P. A., & Doevendans, P. A. (2019). Prevalence and cardiac phenotype of patients with aphospholamban mutation. Netherlands Heart Hournal, 27(2), 64-69. https://doi.org/10.1007/s12471-018-1211-4

Tieleman, R. G., & Hemels, M. E. W. (2019). Mobile health: solution or a threat? Netherlands Heart Hournal, 27(1), 16-17. https://doi.org/10.1007/s12471-018-1206-1

Eurlings, C. G. M. J., Boyne, J. J., de Boer, R. A., & Brunner-La Rocca, H. P. (2019). Telemedicine in heart failure-more than nice to have? Netherlands Heart Hournal, 27(1), 5-15. https://doi.org/10.1007/s12471-018-1202-5

Maass, A. H., Hemels, M. E. W., & Allaart, C. P. (2018). Magnetic resonance imaging in patients with cardiac implantable electronic devices. Netherlands Heart Hournal, 26(12), 584-590. https://doi.org/10.1007/s12471-018-1192-3

Hogervorst, E. K., Rosseel, P. M. J., van de Watering, L. M. G., Brand, A., Bentala, M., van der Meer, B. J. M., & van der Bom, J. G. (2018). Prospective validation of the EuroSCOREII risk model in asingle Dutch cardiac surgery centre. Netherlands Heart Hournal, 26(11), 540-551. https://doi.org/10.1007/s12471-018-1161-x

Linssen, G. C. M., Jaarsma, T., Hillege, H. L., Voors, A. A., & van Veldhuisen, D. J. (2018). A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure. Netherlands Heart Hournal, 26(10), 486-492. https://doi.org/10.1007/s12471-018-1145-x

IJsselmuiden, A. J. J., Zwaan, E. M., Oemrawsingh, R. M., Bom, M. J., Dankers, F. J. W. M., de Boer, M. J., Camaro, C., van Geuns, R. J. M., Daemen, J., van der Heijden, D. J., Jukema, J. W., Kraaijeveld, A. O., Meuwissen, M., Scholzel, B. E., Pundziute, G., van der Harst, P., van Ramshorst, J., Dirksen, M. T., Zivelonghi, C., ... Kedhi, E. (2018). Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology. Netherlands Heart Hournal, 26(10), 473-483. https://doi.org/10.1007/s12471-018-1143-z

Kamali-Sadeghian, M., Bot, P. T. G., Tukkie, R., Wellens, H. J., & van Doorn, D. J. (2018). A peek behind the curtain. Netherlands Heart Hournal, 26(9), 469-470. https://doi.org/10.1007/s12471-018-1138-9

Maass, A. H., & Yap, S. C. (2018). Imaging before cardiac resynchronisation therapy implantation-luxury or necessity? Netherlands Heart Hournal, 26(9), 422-424. https://doi.org/10.1007/s12471-018-1140-2

Mulder, B. A., Maass, A. H., & Blaauw, Y. (2018). Inappropriate shock caused by P wave oversensing in an entirely subcutaneous ICD. Netherlands Heart Hournal, 26(7-8), 411-412. https://doi.org/10.1007/s12471-018-1099-z

Jacobs, M. S., & Tieleman, R. G. (2018). Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much! Netherlands Heart Hournal, 26(6), 334-340. https://doi.org/10.1007/s12471-018-1120-6

Damman, K., Brugemann, J., De Boer, R. A., Erasmus, M. E., & van den Broek, S. A. J. (2018). Heart transplantation in the Netherlands A national achievement. Netherlands Heart Hournal, 26(4), 223-224. https://doi.org/10.1007/s12471-018-1090-8

Erkuner, O., Rienstra, M., Van Gelder, I. C., Schotten, U., Crijns, H. J. G. M., & Luermans, J. G. L. M. (2018). Stroke risk in patients with device-detected atrial high-rate episodes. Netherlands Heart Hournal, 26(4), 177-181. https://doi.org/10.1007/s12471-017-1047-3

van der Linde, I. H. M., Hiemstra, Y. L., Bokenkamp, R., van Mil, A. M., Breuning, M. H., Ruivenkamp, C., ten Broeke, S. W., Veldkamp, R. F., van Waning, J. I., van Slegtenhorst, M. A., van Spaendonck-Zwarts, K. Y., Deprez, R. H. L., Herkert, J. C., Boven, L., van der Zwaag, P. A., Jongbloed, J. D. H., Bootsma, M., & Barge-Schaapveld, D. Q. C. M. (2017). A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects. Netherlands Heart Hournal, 25(12), 675-681. https://doi.org/10.1007/s12471-017-1037-5

Lameijer, H., Kwant, M., & Doff-Holman, M. (2017). Snow white. Netherlands Heart Hournal, 25(12), 697–698. https://doi.org/10.1007/s12471-017-1020-1

Lameijer, H., Kwant, M., & Doff-Holman, M. (2017). Snow white. Netherlands Heart Hournal, 25(12), 691-692. https://doi.org/10.1007/s12471-017-1017-9

van Barreveld, M., Dijkgraaf, M. G. W., Hulleman, M., Boersma, L. V. A., Delnoy, P. P. H. M., Meine, M., Tuinenburg, A. E., Theuns, D. A. M. J., van der Voort, P. H., Kimman, G. P., Buskens, E., Tijssen, J. P. G., Bruinsma, N., Verstraelen, T. E., Zwinderman, A. H., van Dessel, P. H. F. M., Wilde, A. A. M., & DO-IT Investigators (2017). Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): Registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator. Netherlands Heart Hournal, 25(10), 574-580. https://doi.org/10.1007/s12471-017-1016-x

de Vries, L. M., Leening, M. J. G., Dijk, W. A., Hooijschuur, C. A. M., Stricker, B. H. C., & van Hemel, N. M. (2017). Trends in service time of pacemakers in the Netherlands: A long-term nationwide follow-up study. Netherlands Heart Hournal, 25(10), 581-591. https://doi.org/10.1007/s12471-017-1024-x

de Vries, L. M., Dijk, W. A., Hooijschuur, C. A. M., Leening, M. J. G., Stricker, B. H. C., & van Hemel, N. M. (2017). Utilisation of cardiac pacemakers over a 20-year period: Results from a nationwide pacemaker registry. Netherlands Heart Hournal, 25(1), 47-55. https://doi.org/10.1007/s12471-016-0880-0

Braber, T. L., Mosterd, A., Prakken, N. H. J., Doevendans, P. A. F. M., Mali, W. P. T. M., Backx, F. J. G., Grobbee, D. E., Rienks, R., Nathoe, H. M., Bots, M. L., & Velthuis, B. K. (2015). Rationale and design of the Measuring Athlete's Risk of Cardiovascular events (MARC) study. Netherlands Heart Hournal, 23(2), 133-138. https://doi.org/10.1007/s12471-014-0630-0

Dello, S. A. W. G., Kievit, C., Dunselman, P. H., & Alings, M. (2014). Loss of consciousness and convulsion induced by a ventricular tachycardia mimicking epilepsy in a patient with noncompaction cardiomyopathy: a case report. Netherlands Heart Hournal, 22(6), 301-303. https://doi.org/10.1007/s12471-013-0442-7

Otten, E., Lekanne Dit Deprez, R. H., Weiss, M. M., van Slegtenhorst, M., Joosten, M., van der Smagt, J. J., de Jonge, N., Kerstjens-Frederikse, W. S., Roofthooft, M. T. R., Balk, A. H. M. M., van den Berg, M. P., Ruiter, J. S., & van Tintelen, J. P. (2010). Recurrent and founder mutations in the Netherlands: Mutation p.K217del in troponin T2, causing dilated cardiomyopathy. Netherlands Heart Hournal, 18(10), 478-485. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954300/?otool=inlugrmlib

Juffermans, L. J. M., Meijering, D. B. M., van Wamel, A., Henning, R. H., Kooiman, K., Emmer, M., de Jong, N., van Gilst, W. H., Musters, R., Paulus, W. J., van Rossum, A. C., Deelman, L. E., & Kamp, O. (2009). Ultrasound and microbubble-targeted delivery of therapeutic compounds: ICIN Report Project 49: Drug and gene delivery through ultrasound and microbubbles. Netherlands Heart Hournal, 17(2), 82-86. https://doi.org/10.1007/BF03086223

Wieringa, N. F., Denig, P., de Graeff, P. A., & Vos, R. (2002). Clinical relevance of the gap between pre-marketing trials and medical practice: the case of the cardiovascular drugs. Netherlands Heart Hournal, 10(11), 441-448. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2499801/

van Gelder, I. C., Hagens, V. E., Kingma, J. H., Bosker, H. A., Kamp, O., Kingma, T., Veeger, N. J. G. M., Bouma, J., TenVergert, E. M., Tijssen, J. G. P., & Crijns, H. J. G. M. (2002). Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design. Netherlands Heart Hournal, 10(3), 118-124. https://www.ncbi.nlm.nih.gov/pubmed/25696077